Skip to main content
ImmuneCited

Research progress on traditional Chinese medicine compounds in autoimmune-related skin diseases.

Yuhan Wang, Pengzhi Bu, Yu Deng, Wenyingzi Zhao, Guangtao Pan
Systematic Review Frontiers in immunology 2025 1 citations
PubMed DOI PDF
<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'pmid\u003D41112251'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Type d'étude
Systematic Review
Population
Review of TCM compounds in autoimmune skin diseases
Intervention
Research progress on traditional Chinese medicine compounds in autoimmune-related skin diseases. None
Comparateur
None
Critère de jugement principal
None
Direction de l'effet
Mixed
Risque de biais
Unclear

Abstract

BACKGROUND: Autoimmune-related skin diseases such as psoriasis, atopic dermatitis (AD), vitiligo, and Sjögren's syndrome (SjS) are characterized by chronic inflammation, immune dysregulation, and complex pathogenesis. Current therapeutic options are limited by side effects, poor efficacy, and high costs. Traditional Chinese medicine (TCM) compounds have demonstrated promising immunomodulatory, anti-inflammatory, and antioxidant effects, offering a novel alternative for managing these conditions. OBJECTIVE: To systematically review the pharmacological activities and therapeutic potential of bioactive compounds derived from traditional Chinese medicine in treating autoimmune-related skin diseases. METHODS: A comprehensive literature review was conducted, focusing on studies that investigated the efficacy, mechanism, and delivery strategies of TCM-derived compounds. Diseases covered include psoriasis, AD, vitiligo, and SjS. Mechanistic pathways such as JAK/STAT, PI3K/AKT, and NF-κB were evaluated alongside compound-specific delivery systems. RESULTS: Numerous TCM compounds, including curcumin, resveratrol, baicalein, berberine, ginsenosides, and paeoniflorin, exhibited therapeutic effects in preclinical and clinical models. These effects were mediated through various pathways, including inhibition of pro-inflammatory cytokines, restoration of skin barrier function, and modulation of immune cell balance. Nano-based delivery systems further enhanced the stability and bioavailability of these compounds. The compounds also showed potential in reducing oxidative stress and improving melanocyte survival in vitiligo, or restoring glandular secretion in SjS. CONCLUSION: TCM compounds present a valuable resource for the development of safer and more effective therapies for autoimmune-related skin diseases. Further studies are warranted to clarify their mechanisms, optimize delivery systems, and validate clinical efficacy. These natural compounds represent a promising direction for future dermatological drug discovery.

En bref

TCM compounds present a valuable resource for the development of safer and more effective therapies for autoimmune-related skin diseases, and represent a promising direction for future dermatological drug discovery.

Full Text

PDF
Loading PDF...

Used In Evidence Reviews

Similar Papers